First Time Loading...

HUTCHMED (China) Ltd
LSE:HCM

Watchlist Manager
HUTCHMED (China) Ltd Logo
HUTCHMED (China) Ltd
LSE:HCM
Watchlist
Price: 313 GBX 1.62% Market Closed
Updated: May 8, 2024

HUTCHMED (China) Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HUTCHMED (China) Ltd
Operating Income Peer Comparison

Comparables:
G
512
U
3933
S
1177
C
570
C
3320

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
HUTCHMED (China) Ltd
LSE:HCM
Operating Income
$18.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Operating Income
HK$2.6B
CAGR 3-Years
14%
CAGR 5-Years
22%
CAGR 10-Years
29%
U
United Laboratories International Holdings Ltd
HKEX:3933
Operating Income
¥3.2B
CAGR 3-Years
36%
CAGR 5-Years
26%
CAGR 10-Years
23%
S
Sino Biopharmaceutical Ltd
HKEX:1177
Operating Income
¥6.5B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
17%
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Operating Income
¥1.4B
CAGR 3-Years
-17%
CAGR 5-Years
-8%
CAGR 10-Years
19%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Operating Income
HK$12.1B
CAGR 3-Years
7%
CAGR 5-Years
0%
CAGR 10-Years
N/A

See Also

What is HUTCHMED (China) Ltd's Operating Income?
Operating Income
18.4m USD

Based on the financial report for Dec 31, 2023, HUTCHMED (China) Ltd's Operating Income amounts to 18.4m USD.